FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
Drugmakers can keep making off-brand weight-loss drugs as FDA backpedals
Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...
The Hill5 天
FDA shakes up weight loss market as Mounjaro shortage ends
But she also emphasized that GLP-1 medications such as Mounjaro and Ozempic are not the only options when it comes to weight loss or diabetes, and significantly more affordable FDA-approved ...
Health on MSN2 天
What the End of a Tirzepatide Shortage Would Mean for Access to Compounded Weight Loss Drugs
In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...
Yahoo4 天
FDA shakes up weight loss market as Mounjaro shortage ends
(The Hill) – Federal regulators shook up the booming weight loss drug marketplace ... Tirzepatide was first approved by the Food and Drug Administration (FDA) in 2022 and has no generic versions ...
Prescott eNews21 小时
Pharmacy Leader Warns of Counterfeit Weight-Loss Drug Crisis – Inside Sources
Millions of Americans rely on a new class of medications to manage chronic conditions like diabetes and obesity, with ...